Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography.

about

Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality.

P2860

Q36800313-D855213E-7DDF-4430-A2C0-131D9D819DED

P2860

Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography.

Item

http://www.wikidata.org/entity/Q35746459

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Tumour characteristics and sur ...... agnosed by annual mammography.

@ast

Tumour characteristics and sur ...... agnosed by annual mammography.

@en

type

Item

label

Tumour characteristics and sur ...... agnosed by annual mammography.

@ast

Tumour characteristics and sur ...... agnosed by annual mammography.

@en

prefLabel

Tumour characteristics and sur ...... agnosed by annual mammography.

@ast

Tumour characteristics and sur ...... agnosed by annual mammography.

@en

P1476

Tumour characteristics and sur ...... agnosed by annual mammography.

@en

P2093

Andrew Wallace

http://www.w3.org/2001/XMLSchema#string

Anne Irene Hagen

http://www.w3.org/2001/XMLSchema#string

Kukatharmini Tharmaratnam

http://www.w3.org/2001/XMLSchema#string

Paula Stavrinos

http://www.w3.org/2001/XMLSchema#string

Pål Møller

http://www.w3.org/2001/XMLSchema#string

Sarah Sampson

http://www.w3.org/2001/XMLSchema#string

P2860

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.

Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer.

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation.

Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02).

MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis.

Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2.

Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.

Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies.

MRI breast screening in high-risk women: cancer detection and survival analysis.

P2888

s10549-015-3448-6

P304

87-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-015-3448-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

152

http://www.w3.org/2001/XMLSchema#string

P50

Gareth Evans

Anthony Howell

Anthony Maxwell

P577

2015-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277782993

http://www.w3.org/2001/XMLSchema#string

P698

26037256

http://www.w3.org/2001/XMLSchema#string

P932

4468806

http://www.w3.org/2001/XMLSchema#string

Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography.

about

P2860

P2860

Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932